BioengineeringCell Reports MedicinePeer-reviewed
Cardiolipin-mimic lipid nanoparticles without antibody modification delivered senolytic in-vivo CAR-T therapy for inflamm-aging
Zihan Zhang, Bin Ma, Buyao Li…·Lei Miao
This study develops cardiolipin-mimic lipid nanoparticles for in vivo CAR-T therapy without antibody modification, treating liver fibrosis and rheumatoid arthritis via circular uPAR CAR mRNA.